India is facing a steady rise in its cancer burden, and the health system is racing to keep pace. Demand for diagnosis and treatment is climbing, while access to that care remains deeply uneven across the country.

At Narayana Health, we see both sides of this picture every day: growing numbers of patients seeking care and the real barriers many face in reaching it. The oncology specialists at Narayana Health work at that front line, and this overview looks at where the demand is coming from and where the gaps in access still lie.

Rising Burden

The scale of the challenge is clear from national data. The Indian Council of Medical Research’s National Cancer Registry Programme estimated about 1.46 million new cancer cases in India in 2022, and projected that number to rise by nearly 13 percent by 2025.

The same programme estimates that one in nine Indians is likely to develop cancer in their lifetime. Lung, breast, oral, and cervical cancers remain among the most common.

These are not distant projections. They translate into rising pressure on hospitals, diagnostic services, and specialist teams right now.

What Is Driving Demand

Several forces are pushing cancer numbers upward at once:

• An ageing population, since cancer risk rises with age
• Lifestyle and environmental factors, including tobacco use, which drives much of India’s oral and lung cancer
• Better detection and reporting, which surfaces cases that once went undiagnosed
• Growing public awareness, bringing more people in for screening and check-ups

Higher demand is not entirely bad news. More diagnoses often mean earlier diagnoses, and earlier diagnosis is one of the strongest predictors of a good outcome.

Access Gap

Where India struggles most is not in recognising cancer but in treating it equitably. Advanced care is concentrated in large cities, while much of the population lives elsewhere.

Radiotherapy illustrates the problem sharply. Analysis in The Lancet Regional Health – Southeast Asia notes that India has only around 779 teletherapy machines, far below what its population requires, and that radiotherapy sees the longest treatment delays of any modality.

The barriers to timely care tend to cluster:

• A shortage and uneven spread of radiotherapy machines and cancer centres
• Too few trained oncologists, especially outside major cities
• The high cost of advanced treatment, which puts it out of reach for many families
• Late presentation, as patients in underserved areas often arrive at an advanced stage

The result is a divide between metro-centric, world-class care and rural regions where basic services can be hard to find.

Where the System Is Responding

The picture is not static. Investment and policy are beginning to shift the landscape.

Government schemes such as Ayushman Bharat have widened financial protection for treatment, and public cancer institutes are expanding. Private and philanthropic hospital networks have carried capacity beyond the metros, extending comprehensive cancer care to more patients.

Technology is helping too. Improved imaging, better pathology, and digital tools are making diagnosis faster and, in some cases, reaching patients who were previously beyond the system’s grasp.

Bridging the Gap

Meeting rising demand fairly will take sustained effort on several fronts:

• Expanding radiotherapy and treatment infrastructure, particularly in underserved states
• Training and retaining more oncologists, surgeons, and specialist nurses
• Strengthening early detection and screening at the primary-care level
• Making treatment more affordable so that cost is not the reason care is delayed

None of these is a quick fix. Together, though, they are what turn a growing patient population from a strain on the system into a story of more lives saved.

Closing the Distance

India’s cancer burden is rising, and it will keep rising for years to come. The demand is real, and so are the gaps in reaching care. 

Closing the distance between where cancer care exists and where it is needed is the defining task ahead, and progress on infrastructure, workforce, early detection, and affordability is what will decide how many of those cases end in recovery.

Stay updated, free articles. Join our Telegram channel

Join